2022 Q3 Form 10-Q Financial Statement
#000182912622014686 Filed on July 27, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $9.440K | $9.610K | $1.350K |
YoY Change | -73.8% | 742.98% | -15.63% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $9.443K | $9.606K | $1.350K |
YoY Change | -73.79% | 745.6% | -15.63% |
Operating Profit | -$9.443K | -$9.606K | |
YoY Change | -73.79% | 745.6% | |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$9.440K | -$9.610K | -$1.350K |
YoY Change | -73.8% | 742.98% | -15.63% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$9.443K | -$9.606K | -$1.353K |
YoY Change | -73.79% | 745.6% | -15.44% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$21.19 | -$21.57 | -$3.03 |
COMMON SHARES | |||
Basic Shares Outstanding | 445.5M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | |||
Short-Term Investments | |||
Other Short-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $0.00 | ||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $0.00 | ||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $0.00 | ||
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $14.70K | $14.70K | $14.70K |
YoY Change | -33.57% | 0.0% | 0.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $20.40K | $10.96K | $1.350K |
YoY Change | -53.83% | -29.61% | -90.65% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $35.11K | $25.66K | $16.06K |
YoY Change | -47.06% | -15.25% | -44.89% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $35.11K | $25.66K | $16.06K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $35.11K | $25.66K | $16.06K |
YoY Change | -47.06% | -15.25% | -44.89% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$630.0K | -$620.5K | |
YoY Change | |||
Common Stock | $445.5K | $445.5K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$35.11K | -$25.66K | -$16.06K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $0.00 | ||
YoY Change |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$9.443K | -$9.606K | -$1.353K |
YoY Change | -73.79% | 745.6% | -15.44% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$9.440K | -$9.610K | -$1.350K |
YoY Change | -66.99% | 742.98% | -15.63% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 9.440K | 9.610K | 1.350K |
YoY Change | -66.99% | 742.98% | -15.63% |
NET CHANGE | |||
Cash From Operating Activities | -9.440K | -9.610K | -1.350K |
Cash From Investing Activities | |||
Cash From Financing Activities | 9.440K | 9.610K | 1.350K |
Net Change In Cash | 0.000 | 0.000 | 0.000 |
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.440K | -$9.610K | -$1.350K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001642365 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
us-gaap |
Revenues
Revenues
|
usd | ||
CY2022Q1 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
usd | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
usd | ||
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
City Area Code
CityAreaCode
|
646 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
768 -8417 | ||
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25663 | usd |
dei |
Entity File Number
EntityFileNumber
|
333-204161 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
ALPINE AUTO BROKERS INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
38-3970138 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1185 Avenue of the Americas | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
3rd Floor | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10036 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
445500000 | shares |
CY2022Q2 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
14704 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
14704 | usd |
CY2022Q2 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
10959 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14704 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
25663 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
14704 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
10000 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
445500000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
445500000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44550000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
44550000 | shares |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
445500 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
44550 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
149347 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
540297 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-620510 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-609551 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-25663 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14704 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9606 | usd |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1136 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10959 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2736 | usd | |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
9606 | usd |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1136 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
10959 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
2736 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9606 | usd |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1136 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10959 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2736 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9606 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1136 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10959 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2736 | usd | |
CY2022Q2 | altb |
Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
|
-0.00 | |
CY2021Q2 | altb |
Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
|
-0.00 | |
altb |
Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
|
-0.00 | ||
altb |
Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
|
-0.00 | ||
CY2022Q2 | altb |
Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
|
445500000 | shares |
CY2021Q2 | altb |
Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
|
44550000 | shares |
altb |
Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
|
44550000 | shares | |
altb |
Basic And Diluted Weighted Average Number Of Ordinary Shares
BasicAndDilutedWeightedAverageNumberOfOrdinaryShares
|
44550000 | shares | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27539 | usd |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1600 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-29139 | usd |
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-1136 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-30275 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14704 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1353 | usd |
altb |
Conversion Of Preferred Stock Shares
ConversionOfPreferredStockShares
|
10000000 | shares | |
us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
400950000 | shares | |
altb |
Conversion Share Price
ConversionSharePrice
|
0.001 | ||
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-16057 | usd |
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-9606 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-25663 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
10959 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
2736 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10959 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2736 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
10959 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
2736 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10959 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2736 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84B_eus-gaap--UseOfEstimates_zZAv6NXCRCpd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zHjjp1DqIOe6">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation of inventory, and recoverability of carrying amount and the estimated useful lives of long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2022Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10959 | usd | |
CY2022Q2 | altb |
Working Capital
WorkingCapital
|
25663 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-620510 | usd |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
445500000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
445500000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
44550000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
44550000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
10959 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
14704 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
14704 | usd |
CY2022Q2 | us-gaap |
Other Commitment
OtherCommitment
|
0 | usd |
CY2021Q4 | us-gaap |
Other Commitment
OtherCommitment
|
0 | usd |
us-gaap |
Revenues
Revenues
|
usd |